Detalles de la búsqueda
1.
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Ann Rheum Dis
; 82(10): 1307-1314, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37541762
2.
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.
Rheumatology (Oxford)
; 62(5): 1824-1833, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165675
3.
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Ann Rheum Dis
; 81(7): 925-936, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641125
4.
Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.
Rheumatology (Oxford)
; 56(7): 1189-1199, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28398504
5.
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.
Joint Bone Spine
; 85(3): 317-322, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549945
6.
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).
Autoimmun Rev
; 16(5): 548-554, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28279841
Resultados
1 -
6
de 6
1
Próxima >
>>